Health economics of endometriosis
OA: closed
CC0
⤵ 7 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper reviews the health economics of endometriosis, covering its prevalence, direct and indirect costs, and the economic impact of diagnostic delays and treatment options.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
Cited by (7)
- Malignant Transformation and Associated Biomarkers of Ovarian Endometriosis: A Narrative Review 2020
- Simple Immunocytochemistry from Menstrual Blood in Diagnosis of Endometriosis 2019
- Update on Biomarkers for the Detection of Endometriosis 2015
- Biomarkers of endometriosis 2013
- The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres 2012
- Endometriosis cost assessment (the EndoCost study): a cost-of-illness study protocol 2010
- Future of endometriosis research 2007
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK